The University of Chicago Header Logo

Comparison Between Adalimumab and Infliximab in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.

Comparison Between Adalimumab and Infliximab in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis. Gastro Hep Adv. 2025; 4(8):100697.

View in: PubMed